Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Working in non-Covid-19 wards and night shifts is linked to higher infection rates among Italian nurses.

Vaccination is the most effective way to reduce COVID-19 transmission.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

COVID-19 survivors may face long-term health issues affecting both mind and body.

COVID-19 may lead to severe skin necrosis without clear underlying causes, as seen in a diabetic patient who required leg amputation.

COVID-19 pneumonia requires more intensive care, including monitoring liver functions and DVT, due to higher D-dimer and procalcitonin levels.

Some skin symptoms, like chilblain-like lesions, can help identify COVID-19 and show how the immune system is responding.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Sex hormones likely did not affect COVID-19 outcomes in South Korea.

COVID-19 may trigger or worsen rapid hair loss in alopecia areata.

Many COVID-19 survivors experience long-term symptoms but still report satisfactory quality of life and return to work.

Targeted interventions based on gender, education, and age can improve COVID-19 healthcare responses.

Fetal-maternal stem cells in a mother's hair can help with tissue repair and regeneration long after childbirth.

The treatment with an oral drug and topical lotion is effective and well-tolerated for hair loss after COVID-19.

Herpes zoster can occur with COVID-19 even in healthy individuals.

Platelet-rich plasma helps treat post-COVID-19 hair loss and boosts self-esteem.

Topical Minoxidil is effective for hair loss after COVID-19.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Many COVID-19 survivors experience long-term symptoms like fatigue and sleep issues, needing ongoing medical support.

Targeting abnormal lung fluid metabolism could reduce COVID-19 deaths and ventilator use.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

AI can effectively detect hair and scalp disorders from images.